Patents by Inventor Paul Schechter

Paul Schechter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8425880
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: April 23, 2013
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Jeffrey B. Lyczak, Katherine Thompson, Katherine Turner, Paul Schechter
  • Publication number: 20130095184
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Application
    Filed: April 25, 2008
    Publication date: April 18, 2013
    Applicant: NUCRYST PHARMACEUTICALS CORP.
    Inventors: Jeffrey B. Lyczak, Katherine Thompson, Katherine Turner, Paul Schechter
  • Patent number: 7470437
    Abstract: Methods of treating conditions with a metal-containing material are disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: December 30, 2008
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert E. Burrell, John B. Wright, Kan Lam, Antony G. Naylor, Peter H. Moxham, Scott H. Gillis, Paul Schechter
  • Patent number: 7427416
    Abstract: Methods of treating conditions using metal-containing materials are disclosed. Exemplary conditions include bacterial conditions, biofilm conditions, microbial conditions, inflammatory conditions, fungal conditions, viral conditions, autoimmune conditions, idiopathic conditions, hyperproliferative conditions, noncancerous growths, cancerous conditions and combinations of such conditions. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: September 23, 2008
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20080014286
    Abstract: Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Application
    Filed: August 14, 2007
    Publication date: January 17, 2008
    Inventors: Scott Gillis, Paul Schechter, James Stiles
  • Publication number: 20080014278
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Application
    Filed: June 22, 2007
    Publication date: January 17, 2008
    Inventors: Cheng Lu, Wen Chen, Khailash Bhol, Jeffrey Lyczak, Paul Schechter
  • Publication number: 20080014247
    Abstract: Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
    Type: Application
    Filed: June 22, 2007
    Publication date: January 17, 2008
    Inventors: Cheng Lu, Paul Schechter, Kailash Bhol, Wen Chen
  • Patent number: 7255881
    Abstract: Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: August 14, 2007
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20060240067
    Abstract: Biocompatible articles and related methods are disclosed.
    Type: Application
    Filed: March 29, 2006
    Publication date: October 26, 2006
    Inventors: Scott Gillis, Steve Chartier, Wen Chen, Cheng Lu, Paul Schechter
  • Patent number: 7078060
    Abstract: Solutions and aerosols of metal-containing compounds are disclosed. Methods of preparing and using the solutions and aerosols, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: July 18, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert E. Burrell, John B. Wright, Kan Lam, Hua Qing Yin, Antony G. Naylor, Peter H. Moxham, Scott H. Gillis, Paul Schechter
  • Publication number: 20060115541
    Abstract: Treatment of bladder conditions is disclosed
    Type: Application
    Filed: October 14, 2005
    Publication date: June 1, 2006
    Inventors: Scott Gillis, Paul Schechter
  • Patent number: 6989157
    Abstract: Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: January 24, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Scott H. Gillis, Paul Schechter, Robert E. Burrell
  • Publication number: 20050136128
    Abstract: Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Application
    Filed: November 29, 2004
    Publication date: June 23, 2005
    Inventors: Scott Gillis, Paul Schechter, Robert Burrell
  • Publication number: 20050129624
    Abstract: Methods of treating conditions with a metal-containing material are disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Application
    Filed: November 10, 2004
    Publication date: June 16, 2005
    Applicant: Nucryst Pharmaceuticals Corp.
    Inventors: Robert Burrell, Scott Gillis, Paul Schechter, Antony Naylor, Peter Moxham, John Wright, Kan Lam
  • Patent number: 6866871
    Abstract: Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: March 15, 2005
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Scott H. Gillis, Paul Schechter, Robert E. Burrell
  • Publication number: 20040191329
    Abstract: Compositions and methods of metal-containing materials of metal-containing materials are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Application
    Filed: October 22, 2003
    Publication date: September 30, 2004
    Inventors: Robert E. Burrell, John B. Wright, Kan Lam, Hua Qing Yin, Antony G. Naylor, Peter H. Moxham, Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20040129112
    Abstract: Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 8, 2004
    Inventors: Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20040131698
    Abstract: Methods of treating conditions using metal-containing materials are disclosed. Exemplary conditions include bacterial conditions, biofilm conditions, microbial conditions, inflammatory conditions, fungal conditions, viral conditions, autoimmune conditions, idiopathic conditions, hyperproliferative conditions, noncancerous growths, cancerous conditions and combinations of such conditions. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 8, 2004
    Inventors: Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20040110738
    Abstract: Prophylactic treatment methods are disclosed. The methods can include contacting an object and/or an area of a subject with a metal-containing material to reduce the occurrence of a condition at the same area or a different area of the subject. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm metal-containing material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, an anti-proliferative material, an MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Application
    Filed: October 22, 2003
    Publication date: June 10, 2004
    Inventors: Scott H. Gillis, Paul Schechter, Robert H. Demling
  • Publication number: 20030206966
    Abstract: Methods of inducing apoptosis and modulating metalloproteinases, particularly with metal-containing compounds, are disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Application
    Filed: October 22, 2002
    Publication date: November 6, 2003
    Inventors: Robert E. Burrell, Scott H. Gillis, Paul Schechter, John B. Wright, Kan Lam